Success Stories: Despite a Long Adjudication Period, NIW Approval Received for an R&D Department Manager in Biomedical Engineering from Iran

 

Client’s Testimonial:

“Thank you so much for all your help during this time. Much appreciated. Thank you so much for all the help with our case preparation and for answering all our questions.”


On May 13th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for an R&D Department Manager in the Field of Biomedical Engineering (Approval Notice).


General Field: Biomedical Engineering

Position at the Time of Case Filing: R&D Department Manager

Country of Origin: Iran

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: May 13th, 2022

Processing Time: 16 months, 26 days


Case Summary:

An Iranian R&D Department Engineer in biomedical engineering came to North America Immigration Law Group seeking help with his EB2-NIW (National Interest Waiver) petition. His work in the area was to develop hydrogels to aid the treatment of infected chronic wounds and to design novel nanomaterials with optimized surface properties that inhibit the formation of microbial biofilms on medical implants. This work improves public health around the globe by helping to prevent infections and thus is of great importance for both the world and the nation. According to the World Health Organization, hundreds of millions of healthcare-associated infections occur every year making our client’s work even more important.

So, while preparing his case, we made sure that the adjudicating authorities also find his work equally significant and approve his NIW petition. This was also made possible because of the many academic and professional records of achievements that he shared with us and our team used in his petition. These records contained some of the following points:

  • He has produced hydrogels that he optimized to promote tissue regeneration and wound healing, which minimizes the risk of infection by allowing patients to recover faster. Such advancements drastically reduce the risk of healthcare-associated infections for patients around the world.
  • His proposed endeavor has broad implications for the United States since his work is valuable in the fight against antibiotic-resistant infections. The Centers for Disease Control and Prevention have stated that about 2.8 million Americans get an antibiotic-resistant infection every year.
  • His work is also beneficial in maintaining the safety of surgical procedures by helping to prevent surgical site infections.
  • Due to its evident national importance, his research has in fact been supported with funding from the National Institutes of Health, the U.S. Department of Defense, the American Heart Association, as well as funding from privately held companies.
  • His research has resulted in 9 peer-reviewed journal articles (1 of them first-authored), 1 peer-reviewed abstract, 1 patent application, and 2 book chapters (both of them co-first-authored) which have been cited a total of 98 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biomedical engineering.
  • Finally, his 4 years of experience in the field has led to a certain degree of reliability due to which he got 5 letters of recommendation from experts in the field. Two of these experts said:
“[The client] advances to nanograin tuning, reductions in antimicrobial resistant bacteria surface proliferation, and improvements to post-implantation patient health advance the field of biomedical engineering. [The client] identification of the relationship between grain size and biofilm formation enables researchers to design more resilient materials for use in biomedical devices and invasive instruments. These advances not only progress biomedical engineering but also strengthen global public health.”

“[The client] is demonstrably reducing the risk of surgical site infection through his groundbreaking research into bioactive nano-grained stainless steel. His research has identified a relationship between the control of certain material features, such as grain size, surface roughness, surface energy, magnetization, and antibacterial properties. Significantly, this has led to the design of medical-grade stainless steel capable of substantially reducing bacterial growth, spread, and adherence. Research of this caliber verifiably benefits the United States through improvements to patient health and reductions in hospital bills.”

So, when his approval came through we were thankful to him for having chosen us and we wish him all the very best for his future endeavors. We are glad that his work benefits the United States of America and the world at large.